Press Releases Year 2004

0) { while($jd=mysql_fetch_array($objrs)) { ?> ' class="matter1"> October 26, 2004 Wockhardt Third Quarter Gross Profit up 32% at Rs. 80 crores. Three products launched in US under Wockhardt banner October 20, 2004 Wockhardt UK sells Luton plant, to ramp up Wales unit October 7, 2004 President Dr. APJ Abdul Kalam lauds Wockhardt Biotech Research, Wockhardt Scientists help lower cost of medicines, Wockhardt develops Glargine, a research breakthrough September 23, 2004 Wockhardt revives the Indian FCCB market with a US $ 100 million issue September 21, 2004 Wockhardt to go for US listing. Plans new European acquisitions of US$100 million, Second Quarter Net up 43% at Rs. 50 crores July 26, 2004 Union Budget Reaction of Habil Khorakiwala, Chairman, Wockhardt July 8, 2004 Wockhardt’s sterile injectable & bulk drug facilities receive US FDA nod in record time July 5, 2004 Wockhardt strengthens European presence with German acquisition May 6, 2004 Wockhardt shareholders approve bonus, share split and dividend April 23, 2004 Wockhardt announces first quarter results of 2004. Net profit up 441% at Rs. 44 crores, Sales up 78% at Rs. 288 crores April 22, 2004 Wockhardt sets up marketing subsidiary for aggressive push into US market April 20, 2004 Former HSBC chief Aman Mehta joins Wockhardt as Director March 10, 2004 Wockhardt's Audited Financial Results 2003. Dividend enhanced to 75%, Proposes 1 Bonus Share for every 2 Shares February 12, 2004

Press Releases 2005   Press Releases Archives Year 2003

Would like to know more about Wockhardt ? Annual Report 2005 Corporate Presentation Chairman’s Letter to Shareowners Investor Update Q2, 2005 Results

Disclaimer:
The company would like to caution that any forward-looking statements or projections made by the company, including those made in the press release announcements, are subject to risks and uncertainties that may cause actual results to differ materially from those projected.